What NxtCells does

NxtCells is a small private biotechnology contract research and research-support services firm. Its website is branded "Biotechnology Contract Research Services — Berlin," but operating signals point to India-based execution as well: the primary contact phone carries an Indian country/area format, the firm's inferred domicile is India, and it is organizing a flagship conference in New Delhi. The company serves academic researchers, biotech startups, and industry professionals with a horizontal segmentation approach and offers six integrated service lines: contract research, event management, research supply (instruments and reagents), genomics (sequencing and bioinformatics), publication support (manuscript and thesis writing), and intellectual property services (patent drafting, filing, and prosecution). The stated value proposition is end-to-end support from research design through IP protection and dissemination.

The underlying technology is a sequencing and bioinformatics service stack rather than a proprietary platform; the firmographic description of a "sequencing and bioinformatics platform" overstates the asset base, as no platform IP, patents, or productized software are documented. Five scientific advisors with verifiable Google Scholar profiles provide domain credibility. The business model is professional services: quote-based, scope-defined engagements with no public pricing. Go-to-market is event-driven and community-led, anchored by the International Congress of Pharmaceutics-Biotechnology (December 23-24, 2025, New Delhi) and supplemented by organic social (Facebook, X, Instagram) and an email newsletter. Distribution is direct via website contact form and email. The firm is GDPR-compliant and treats data processing under Art. 6 EU DSGVO/GDPR.

The firm is small (11-50 employees), uses a Gmail address for primary contact, has no disclosed funding, no named enterprise customers, and no proprietary technology assets, which together characterize it as an early-stage, sub-scale services business rather than a venture-backable technology company.

Name

NxtCells

Legal name

Nxtcells

Website

https://nxtcells.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

NxtCells is a small private Berlin-headquartered (with India-linked operations) biotechnology contract research and research-support services firm serving academic researchers, biotech startups, and industry professionals with contract research, genomics, event management, research supply, publication, and IP services.

Ownership category

akta.pro rank

Product category

Biotechnology Contract Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

akta.pro secondary industry

Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)

Keywords

• Contract research services
• Biotechnology research support
• Event management services
• Genomics research services
• Publication and IP support

Headquarters

HQ city

Menlo Park

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Contract Research Services: The primary revenue stream involves providing contract research services to biotech companies, startups, and academic researchers. Services include experimental planning, data analysis, and technology development support.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

NxtCells operates as a research-support platform for the biotechnology industry, providing contract research services spanning genomics, research supply, publication support, and intellectual property services. The company also manages biotechnology-focused event management, operating from its Berlin headquarters with delivery operations in India.

Product overview

NxtCells operates as a dedicated research-support platform offering biotechnology contract research and event management services. The company provides a unified portfolio of interconnected services: Contract Research Services for collaborative scientific discovery; Event Management for seminars and workshops; Research Supply for instruments and reagents; Genomics Services including sequencing and bioinformatics; Publication Support for manuscript writing and journal publication; and Intellectual Property Services for patent drafting and prosecution. These services are designed to support researchers, academicians, startups, and industry professionals in advancing scientific innovation from discovery through dissemination.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Research Services Outsourced research execution services for biotechnology organizations, delivered via project-based engagements to clients needing specialized scientific capabilities.
• Event Management Services End-to-end event management tailored for biotechnology conferences, summits, and industry gatherings, delivered by NxtCells for biotech clients and partners.
• Research Supply Services Procurement and supply of research-related materials and resources required by biotechnology clients to execute their research programs.
• Genomics Services Genomics-focused research support services for biotechnology clients, executed through the company's scientific operations and advisory bench.
• Publication Support Services Assistance with scientific publication preparation for biotechnology research, supporting clients in drafting, editing, and submitting research outputs.
• Intellectual Property Services Advisory and support services related to intellectual property management for biotechnology organizations, complementing the company's research and publication offerings.

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• GenScript: Integrated biotech services and reagent provider offering gene synthesis, protein production, and cell therapy support. Comparable to NxtCells in combining contract research services with research supply (reagents/instruments) for academic and biotech customers.
• Editage: Scientific editing, manuscript preparation, and publication support services for researchers globally. Directly comparable to NxtCells' publication support and thesis writing service line for the academic biotech community.
• Sino Biological: Biotech reagent supplier and CRO offering proteins, antibodies, and custom services for life science research. Comparable to NxtCells as a multi-service platform combining reagent supply with contract research support for the biotech community.
• Novogene: Global sequencing and bioinformatics services provider with significant Asia and Europe footprint. Comparable to NxtCells' sequencing service line and mirrors the Berlin/India cross-border operating geography that NxtCells exhibits.
• CD Genomics: Genomics services company providing sequencing, bioinformatics, and multi-omics contract research. Directly comparable to NxtCells' genomics/sequencing service line and the bioinformatics publication-ready output the company advertises.
• Enago: Scientific editing and publication support provider serving researchers and institutions. Comparable to NxtCells for the manuscript writing, editing, and high-impact journal publication support offering.
• Boster Biological Technology: Antibody and reagent manufacturer with custom research services for academic and biotech researchers. Comparable to NxtCells as a reagent supply and contract research provider targeting publication-driven academic customers.
• Creative Biolabs: A CRO specializing in antibody discovery, engineering, and recombinant protein services for biotech researchers. Closely comparable to NxtCells as a contract research services provider serving academic and startup biotech clients across multiple service lines.

Broad incumbents

• Bio-Techne: Large incumbent life science tools and reagents company with proteomics and genomics services. Comparable to NxtCells as a research supply and contract services provider, but at significantly larger scale and broader portfolio.
• Medpace: Mid-to-large CRO providing full-service clinical development for biotech. Comparable to NxtCells as a contract research services firm for biotech, though operating at vastly larger scale and focused on clinical rather than pre-clinical/research support.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NxtCells